Brand Intelligence Graph
Company Overview
About Gameto
Gameto is revolutionizing in vitro fertilization by engineering ovarian granulosa cells from stem cells that can mature patient eggs in the lab, eliminating the lengthy and hormone-intensive stimulation protocols required by conventional IVF. The company's Fertilo technology co-incubates patient egg cells with Gameto's lab-grown granulosa cells, achieving maturation in 2–3 days versus the 10+ days of hormone injections that characterize standard IVF stimulation.
Business Model & Competitive Advantage
Founded in 2021 by Harvard reproductive biologists, Gameto has demonstrated clinical proof-of-concept with its granulosa cell co-culture system and is advancing toward broader clinical adoption. The $70M Series B will fund pivotal trial design and manufacturing scale-up for commercial launch. The technology could make IVF accessible to patients who cannot tolerate hormone stimulation due to polycystic ovary syndrome (PCOS) or cancer treatment history.
Competitive Landscape 2025–2026
The global IVF market exceeds $25B annually with 8 million cycles performed worldwide, yet completion rates remain below 40% due to egg quality issues. Gameto's platform directly addresses egg maturation quality through the cell biology rather than through hormonal manipulation, potentially improving both success rates and patient experience simultaneously.
Key Differentiators
Emerging Innovator
Gameto is an emerging player bringing innovative solutions to the BioTech market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Pliant Therapeutics
Pliant Therapeutics develops small molecule integrin inhibitors targeting the pathological tissue scarring (fibrosis) that drives diseases including idiopathic pulmonary fibrosis (IPF), primary sclero
BioNTech
BioNTech SE was founded in 2008 in Mainz, Germany by Ugur Sahin, Ozlem Tureci, and Christoph Huber with a mission to harness the immune system for individualized cancer treatment. The company pioneere
Genentech
Genentech was founded in 1976 in South San Francisco by Herbert Boyer and Robert Swanson, becoming the first company to produce human insulin using recombinant DNA technology and essentially launching
Illumina
Illumina was founded in 1998 in San Diego and has grown into the undisputed leader in next-generation sequencing (NGS), with approximately 80% global market share across research and clinical applicat
Regeneron
Regeneron Pharmaceuticals was founded in 1988 in Tarrytown, New York by Leonard Schleifer and George Yancopoulos. The company built its reputation on the Velocimmune platform—a proprietary humanized m
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
Compare Gameto with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Gameto? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Gameto Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Gameto vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →